Ronovo Surgical Completes Series A Financing, Aims to Transform Surgery with Innovations Focused on Simplicity, Precision and Intelligence

24 Apr, 2021

Ronovo Surgical Completes Series A Financing, Aims to Transform Surgery with Innovations Focused on Simplicity, Precision and Intelligence
Photo by Paico Oficial on Unsplash

– Ronovo Surgical, an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery to address the tremendous needs of the Chinese surgical market, recently announced successful closing of Series A financing.
– The Series A financing was co-led by Matrix Partners China and Vivo Capital, with strong, continued support from seed investor Lilly Asia Ventures (LAV) and participation from GGV Capital.
– Developed by renowned surgeons, medtech veterans and robotics experts, Ronovo was founded in Shanghai in 2019 to establish a transformative technology platform that democratizes MIS and digital surgery in the vastly underserved Chinese surgical market.
– By focusing on the three pillars of simplicity, precision, and intelligence, Ronovo is positioning itself as a gateway to China for cutting edge MIS and digital surgery technology companies from around the world.

Eastern Asia Health Care Machine Learning Medical Device Robotics
Crunchbase icon

Content report

The following text will be sent to our editors: